**6. References**


septal defect or closure of ductus arteriosus. In patients with residual defects, like pulmonary stenosis or pulmonary arterial hypertension, serial measurements of BNP or NTproBNP levels provide a useful, easy and non-invasive tool for follow-up and it can be used for quantification of the disease severity. During the follow-up of cardiac transplant patients

Natriuretic peptide levels are age dependent and show significant variability according to the type of the cardiac malformation and the actual hemodynamic condition. Recently, age related normal values have been established in the neonatal period and it allows detection of the congental heart disease in different age groups. Right sided hemodynamic ventricular stress is encountered with lower BNP values. Preoperative and postoperative application of natriuretic peptides provides a useful tool for the detection of postoperative complications. The new analyte, NT-proXNP seems to have promising characteristics, because it reflects the

TAMOP TAMOP-4.2.2/B10/1.-2010-0013, who has sponsored the preparation of this

Ala-Kopsala M, Ruskoaho H, Leppaluoto J, Seres L, Skoumal R, Tóth M, Horkay F,

Albers S, Mir TS, Hada M, Laer S. (2006)N-terminal probrain natriuretic peptide: normal

Baumgartner H, Bonhoeffer P, De Groot NM, de Haan F, Deanfield JE, Galie N, et al. (2010)

Berry JG, Askovich B,.Shaddy A, Hawkins J, Cowley CG (2008) Prognostic Value of B-Type

Breuer T, Sápi E, Skoumal R, Tóth M, Ala-Kopsala M, Vuolteenaho O, Leppäluoto J,

Breuer T, Skoumal R, Horkay F, Merkely B, Ala-Kopsala M, Leppäluoto J, Vuolteenaho O,

Cantinotti M, Vittorini S, Storti S, Prontera C, Murzi M, De Lucia V, et al.(2009) Diagnostic

Vuolteenaho O. (2005) Single assay for amino-terminal fragments of cardiac A- and

ranges in the pediatric population including method comparison and

ESC Guidelines for the management of grown-up congenital heart disease (new version 2010): the Task Force on the Management of Grown-up Congenital Heart Disease of the European Society of Cardiology (ESC). *Eur Heart J* Vol;31 pp 2915–57.

Natriuretic Peptide in Surgical Palliation of Children with Single-Ventricle

Ruskoaho H, Szatmári A, Székely A. (2007) N-terminal pro-brain natriuretic peptide level inversely correlates with cardiac index after arterial switch operation

Ruskoaho H, Tóth M., Székely A. (2010)Strong relationship between NT-proXNP levels and cardiac output following cardiac surgery in neonates and infants. *Acta* 

accuracy and clinical relevance of brain natriuretic peptide assay in pediatric

rejection can be detected by increase of BNP levels.

cardiac output changes earlier than the BNP, NT-proBNP assay.

B-type natriuretic peptides. *Clin Chem* Vol 51 pp 708-18.

Congenital Heart Disease. *PediatrCardiol*, Vol 29 pp 70–75

in neonates. *Pediatric Anesthesia* Vol 17 pp 782-8..

*Anaesthesiologica Scandinavica*; Vol 54 pp 502-9.

interlaboratory variability*. Clin Chem Lab Med* Vol.44 pp 80-85.

**4. Conclusion** 

**5. Acknowledgment** 

chapter.

**6. References** 

patients with congenital heart diseases. J Cardiovasc Med (Hagerstown) Vol 10 pp 706–13


Hama N, Itoh H, Shirakami G, Nakagawa O, Suga S, Ogawa Y, Masuda I, Nakanishi K,

Heise G, Lemmer J, Hübler M, Weng Y, Alexi-Meskishvili V, Böttcher W, Hetzer R, Berger F,

Holmgren D, Westerlind A, Lundberg PA, Wåhlander H. (2005) Increased plasma levels of

Hsu JH, Keller RL, Chikovani O, Cheng H, Hollander SA, Karl TR, Azakie A, Adatia I, Oishi

Jenkins KJ (2004) Risk adjustement for congenital heart surgery: the RACHS-1 method. Sem

Joseph L, Nir A, Hammerman C, Goldberg S, Shalom EB, Picard E (2010)N-terminal pro-B-

Kaneko K, Yoshimura K, Ohashi A, Kimata T, Shimo T, Tsuji S (2011) Prediction of the Risk

Kangawa K, Fukuda A, Kubota I, Hayashi Y, Minamitake Y, Matsuo H. (1984)Human atrial

Kato K, Murakimo H, Isozaki O Endocrine J, Thushima T, Takano K (2009) Serum

Knirsch W, Häusermann E, Fasnacht M, Hersberger M, Gessler P, Bauersfeld U (2011)

Koch A, Singer M. Normal values of B type natriuretic peptide in infants, children, and

Koch A, Kitzsteiner T, Zink S, Cesnjevar R, Singer H. Impact of cardiac surgery on plasma

Kucher N, Printzen G, Goldhaber SZ. (2003) Prognostic role of brain natriuretic peptide in

Kunii Y, Kamada M, Ohtsuki S, Araki T, Kataoka K, Kageyama M. (2003) Plasma brain

acute pulmonary embolism. Circulation; Vol 107 pp 2545–2547.

with congenital heart disease. Acta Med Okayama; Vol 57 pp 191–7

neonatal cardiac surgery. *J Thorac Cardiovasc Surg*; Vol 134 pp 939-45. Hsu JH, Oishi PE, Keller RL, Chikovani O, Karl TR, Azakie A, et al. (2008) Perioperative B-

Thorac Cardiovas Surg Pediatr Card Surg Annu, Vol 7 pp 180-184

acute myocardial infarction. Circulation; Vol 92 pp 1558-64.

in Children. *J Heart Lung Transplant*, Vol 27 pp 150–7

*Physiol Funct Imaging*; Vol 25 pp 263-9.

Infants. *Am J Perinatol*, Vol 27 pp 381–386

*Pediatr Cardiol*, DOI10.1007/s00246-011-9986-8

activity. J Hypertens Suppl; Vol 2 pp S321-3.

adolescents. (2003) *Heart*; Vol 89 pp 875–8.

ActaPædiatrica ISSN0803–5253

Int J Cardiol; Vol 114 pp 339–44.

135 pp 746–53

56 pp 17-27

Yoshimasa T, Hashimoto Y, Yamaguchi M, Hori R, Yasue H, Nakao K. (1995) Rapid ventricular induction of brain natriuretic peptide gene expression in experimental

Stiller B (2008) Biomarker Responses During Mid-term Mechanical Cardiac Support

natriuretic peptide type B and A in children with congenital heart defects with left compared with right ventricular volume overload or pressure overload. *Clin* 

P, Fineman JR. (2007) B-type natriuretic peptide levels predict outcome after

type natriuretic peptide levels predict outcome after bidirectional cavopulmonary anastomosis and total cavopulmonary connection. J Thorac Cardiovasc Surg; Vol

type Natriuretic Peptide as a Marker of Bronchopulmonary Dysplasia in Premature

of Coronary Arterial Lesions in Kawasaki Disease by Brain Natriuretic Peptide.

natriuretic polypeptides (hANP): purification, structure synthesis and biological

Concentrations of BNP and ANP in patients with thyreotoxicosis. *Endocrine J*, Vol

PlasmaB-type natriuretic peptide levels in children with heart disease.

levels of B-type natriuretic peptide in children with congenital heart disease (2007).

natriuretic peptide and the evaluation of volume overload in infants and children

